| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA4836334 | B | Inhibition of HPGDS in rat RBL cells assessed as reduction in PGD2 formation using PGH2 as substrate by mass spectrometry | Rattus norvegicus | 12 | cell-based format | Scientific Literature | ||
| 2. | ALA4836335 | A | Metabolic stability mouse liver S9 fraction assessed as half life | Mus musculus | 8 | subcellular format | Scientific Literature | ||
| 3. | ALA4836336 | B | Inhibition of human HPGDS assessed as reduction in PGD2 formation using PGH2 as substrate by mass spectrometry | Homo sapiens | 19 | single protein format | Scientific Literature | ||
| 4. | ALA4836337 | P | Solubility of the compound in FaSSIF | 15 | small-molecule physicochemical format | Scientific Literature | |||
| 5. | ALA4836338 | A | Dose normalized AUC in mouse at 3 mg/kg, po | Mus musculus | 5 | organism-based format | Scientific Literature | ||
| 6. | ALA4836339 | A | Terminal half life in mouse at 3 mg/kg, po | Mus musculus | 5 | organism-based format | Scientific Literature | ||
| 7. | ALA4836340 | A | Cmax in mouse at 3 mg/kg, po | Mus musculus | 5 | organism-based format | Scientific Literature | ||
| 8. | ALA4836341 | A | Apparent permeability of the compound by PAMPA | 4 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!